Files
OpenBB/website/content/terminal/reference/stocks/ins/lpsb.md
DidierRLopes 4ad995fdd0 Docs/terminalpro and improvement (#5622)
* add first iteration of content for Terminal Pro

* Update index.md

* Update dashboards.md

* Update folders.md

* Update grouping.md

* Update report.md

* Update templates.md

* Update quick-start.md

* Update index.md

* Update index.md

* Update home.md

* Update news.md

* Update index.md

* Update index.md

* Update index.md

* Update data-provider.md

* Update chat-with-widget.md

* Update data-manipulation.md

* Update forecasting.md

* fix: images self closing tags

* fix: only pro visitors can see pro

* inter font

* improve SEO content and restructuring

* add new package for toggle on tutorials

* move folder around

* improve main page of each prod

* small updates and improvements

* fix logo above

* small improvement in headtitle for portfolio funcs

* fix typos from OpenAI's GPT-4

* fix _category_ json

* remove generic SEO words

* add script that generates SEO for documentation

* add missing file

* remove sdk warning message

* fix links for andrew

---------

Co-authored-by: jose-donato <zmcdonato@gmail.com>
Co-authored-by: jose-donato <43375532+jose-donato@users.noreply.github.com>
Co-authored-by: andrewkenreich <andrew.kenreich@gmail.com>
2023-10-30 21:01:29 +00:00

12 KiB
Vendored

title, description, keywords
title description keywords
lpsb The lpsb page provides a user guide on how to use the lpsb command to print the latest penny stock buys. It shows parameters and usage examples, making it easier for users to understand and use this function in their stock market analysis.
penny stocks
stock buy
lpsb command
user guide
stock analysis
command usage
data analysis
stock market
trade data

import HeadTitle from '@site/src/components/General/HeadTitle.tsx';

Print latest penny stock buys. [Source: OpenInsider]

Usage

lpsb [-l LIMIT]

Parameters

Name Description Default Optional Choices
limit Limit of datarows to display 10 True None

Examples

2022 Feb 16, 08:13 (🦋) /stocks/ins/ $ lpsb
                                                                                Insider Data
┏━━━━┳━━━━━━━━━━━━━┳━━━━━━━━━━━━┳━━━━━━━━┳━━━━━━━━━━━━━━━━━━━┳━━━━━━━━━━━━━━━━━━━━━━┳━━━━━━━━━━━┳━━━━━━━━━━━━━━┳━━━━━━━┳━━━━━━━━━━━━┳━━━━━━━━━━━━┳━━━━━━━━━━┳━━━━━━━━━━━━━━┓
┃ X  ┃ Filing Date ┃ Trade Date ┃ Ticker ┃ Company Name      ┃ Insider Name         ┃ Title     ┃ Trade Type   ┃ Price ┃ Qty        ┃ Owned      ┃ Diff Own ┃ Value        ┃
┡━━━━╇━━━━━━━━━━━━━╇━━━━━━━━━━━━╇━━━━━━━━╇━━━━━━━━━━━━━━━━━━━╇━━━━━━━━━━━━━━━━━━━━━━╇━━━━━━━━━━━╇━━━━━━━━━━━━━━╇━━━━━━━╇━━━━━━━━━━━━╇━━━━━━━━━━━━╇━━━━━━━━━━╇━━━━━━━━━━━━━━┩
│ M  │ 2022-02-16  │ 2022-02-09 │ ZIVO   │ Zivo Bioscience,  │ Maggiore Christopher │ Dir, 10%  │ P - Purchase │ $3.72 │ +91,334    │ 803,105    │ +13%     │ +$340,098    │
│    │ 06:02:09    │            │        │ Inc.              │ D.                   │           │              │       │            │            │          │              │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼───────────┼──────────────┼───────┼────────────┼────────────┼──────────┼──────────────┤
│ D  │ 2022-02-15  │ 2021-07-12 │ VGZ    │ Vista Gold Corp   │ Sun Valley Gold      │ 10%       │ P - Purchase │ $1.10 │ +1,300,000 │ 19,922,544 │ +7%      │ +$1,430,000  │
│    │ 16:34:28    │            │        │                   │ Master Fund, Ltd     │           │              │       │            │            │          │              │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼───────────┼──────────────┼───────┼────────────┼────────────┼──────────┼──────────────┤
│ M  │ 2022-02-14  │ 2022-02-10 │ SNSE   │ Sensei            │ Peyer James          │ Dir, 10%  │ P - Purchase │ $4.45 │ +17,500    │ 5,175,786  │ 0%       │ +$77,900     │
│    │ 19:19:52    │            │        │ Biotherapeutics,  │                      │           │              │       │            │            │          │              │
│    │             │            │        │ Inc.              │                      │           │              │       │            │            │          │              │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼───────────┼──────────────┼───────┼────────────┼────────────┼──────────┼──────────────┤
│ M  │ 2022-02-14  │ 2022-02-10 │ SNSE   │ Sensei            │ Cambrian Biopharma   │ 10%       │ P - Purchase │ $4.45 │ +17,500    │ 5,175,786  │ 0%       │ +$77,900     │
│    │ 19:18:48    │            │        │ Biotherapeutics,  │ Inc                  │           │              │       │            │            │          │              │
│    │             │            │        │ Inc.              │                      │           │              │       │            │            │          │              │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼───────────┼──────────────┼───────┼────────────┼────────────┼──────────┼──────────────┤
│ M  │ 2022-02-14  │ 2022-02-10 │ IMRA   │ Imara Inc.        │ Mott David M         │ Dir       │ P - Purchase │ $1.23 │ +31,826    │ 31,826     │ New      │ +$39,246     │
│    │ 17:02:52    │            │        │                   │                      │           │              │       │            │            │          │              │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼───────────┼──────────────┼───────┼────────────┼────────────┼──────────┼──────────────┤
│ D  │ 2022-02-11  │ 2022-02-09 │ ARMP   │ Armata            │ Innoviva, Inc.       │ Dir, 10%  │ P - Purchase │ $5.00 │ +3,614,792 │ 19,691,561 │ +22%     │ +$18,073,960 │
│    │ 18:56:05    │            │        │ Pharmaceuticals,  │                      │           │              │       │            │            │          │              │
│    │             │            │        │ Inc.              │                      │           │              │       │            │            │          │              │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼───────────┼──────────────┼───────┼────────────┼────────────┼──────────┼──────────────┤
│ M  │ 2022-02-11  │ 2022-02-09 │ EMMA   │ Emmaus Life       │ Niihara Yutaka       │ COB, CEO, │ P - Purchase │ $1.46 │ +30,500    │ 11,350,200 │ 0%       │ +$44,385     │
│    │ 17:00:36    │            │        │ Sciences, Inc.    │                      │ 10%       │              │       │            │            │          │              │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼───────────┼──────────────┼───────┼────────────┼────────────┼──────────┼──────────────┤
│ M  │ 2022-02-10  │ 2022-02-08 │ REVB   │ Revelation        │ Tidmarsh George F    │ Dir, 10%  │ P - Purchase │ $2.55 │ +31,000    │ 1,970,491  │ +2%      │ +$79,139     │
│    │ 18:22:45    │            │        │ Biosciences, Inc. │                      │           │              │       │            │            │          │              │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼───────────┼──────────────┼───────┼────────────┼────────────┼──────────┼──────────────┤
│ D  │ 2022-02-09  │ 2022-02-08 │ MYPS   │ Playstudios, Inc. │ Pascal Andrew S      │ COB, CEO, │ P - Purchase │ $4.77 │ +25,700    │ 16,242,900 │ 0%       │ +$122,602    │
│    │ 19:36:53    │            │        │                   │                      │ 10%       │              │       │            │            │          │              │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼───────────┼──────────────┼───────┼────────────┼────────────┼──────────┼──────────────┤
│ AM │ 2022-02-09  │ 2022-02-04 │ REVB   │ Revelation        │ Tidmarsh George F    │ Dir, 10%  │ P - Purchase │ $2.56 │ +52,000    │ 1,939,491  │ +3%      │ +$132,936    │
│    │ 16:24:52    │            │        │ Biosciences, Inc. │                      │           │              │       │            │            │          │              │
└────┴─────────────┴────────────┴────────┴───────────────────┴──────────────────────┴───────────┴──────────────┴───────┴────────────┴────────────┴──────────┴──────────────┘
A: Amended filing
D: Derivative transaction in filing (usually option exercise)
M: Multiple transactions in filing; earliest reported transaction date & weighted average transaction price